PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.
Show more...
CEO
Mr. Michael J. Valentino
직원
16
국가
US
ISIN
US72942A1079
WKN
000A2DMUN
상장
0 Comments
생각을 공유하기
FAQ
오늘 PLx Pharma 주가는 얼마인가요?▼
PLXPQ의 현재 가격은 $0 USD이며, 지난 24시간 동안 +0% 상승했습니다. 차트에서 PLx Pharma 주가 흐름을 더 자세히 살펴보세요.
PLx Pharma의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, 거래소에서는 PLx Pharma 주식이 PLXPQ 심볼로 거래됩니다.